Clinical Trials Logo

Apraxias clinical trials

View clinical trials related to Apraxias.

Filter by:

NCT ID: NCT02199093 Completed - Stroke Clinical Trials

Functional Rehabilitation of Upper Limb Apraxia in Patients Poststroke

Start date: May 2014
Phase: N/A
Study type: Interventional

The purpose of this study is to analyze the effects of a mixed intervention of occupational therapy (rehabilitative and compensatory approach) at home to upper limb apraxia in mild and moderate patients post stroke in comparison to a control group with a traditional health educative protocol.

NCT ID: NCT02094014 Recruiting - Clinical trials for Cerebrovascular Accident

Auditory Masking Effects on Speech Fluency in Aphasia and Apraxia of Speech

Start date: March 2014
Phase: N/A
Study type: Observational

Impaired speech production is a major obstacle to full participation in life roles by stroke survivors with aphasia and apraxia of speech. The proposed study will demonstrate the short-term effects of auditory masking on speech disfluencies and identify individual factors that predict a positive response, enabling future work to develop auditory masking as a treatment adjuvant targeting long-term improvement in speech. Providing an additional treatment option for adults with aphasia and apraxia of speech will have the clear benefit of improving quality of life and allowing individuals to participate more actively in their health care decisions through improved communication.

NCT ID: NCT02046941 Completed - Stroke Clinical Trials

Brain Biomarkers of Response to Treatment for Apraxia of Speech

SPT
Start date: March 1, 2014
Phase: N/A
Study type: Interventional

The study will use MRI brain imaging to identify brain changes associated in stroke patients after they receive speech-language treatment for their speech difficulties.

NCT ID: NCT01979159 Completed - Aphasia Clinical Trials

A Novel Treatment for Aphasia and Apraxia of Speech : Measurement of Outcomes

Start date: October 21, 2013
Phase: N/A
Study type: Interventional

In order to determine if speech-language therapy has positive effect, reliable measurement tools are required to document outcomes. Currently, there is very limited information concerning the measurement of changes in speech production as a result of treatment for acquired apraxia of speech and aphasia. This study will obtain information concerning the reliability of several speech production measures over time. Thirty persons with chronic aphasia and apraxia of speech will be asked to provide speech samples in response to commonly used assessment tools on three sampling occasions so that the stability of measurements may be examined. After establishment of appropriate outcome measures, a small, pilot treatment study will be conducted with four participants. The participants will receive a new treatment for aphasia and acquired apraxia of speech and outcomes will be measured relative to speech and language production.

NCT ID: NCT01818661 Recruiting - Clinical trials for Primary Progressive Aphasia

Longitudinal Multi-Modality Imaging in Progressive Apraxia of Speech

Start date: July 1, 2018
Phase: Phase 4
Study type: Interventional

The study is designed to determine the relationship between structural and functional changes in the brain on imaging and progression of speech and language, neurological and neuropsychological features in patients with neurodegenerative apraxia of speech (AOS).

NCT ID: NCT01793168 Recruiting - Clinical trials for Retinitis Pigmentosa

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

CoRDS
Start date: July 2010
Phase:
Study type: Observational [Patient Registry]

CoRDS, or the Coordination of Rare Diseases at Sanford, is based at Sanford Research in Sioux Falls, South Dakota. It provides researchers with a centralized, international patient registry for all rare diseases. This program allows patients and researchers to connect as easily as possible to help advance treatments and cures for rare diseases. The CoRDS team works with patient advocacy groups, individuals and researchers to help in the advancement of research in over 7,000 rare diseases. The registry is free for patients to enroll and researchers to access. Visit sanfordresearch.org/CoRDS to enroll.

NCT ID: NCT01623284 Completed - Aphasia Clinical Trials

PiB PET Scanning in Speech and Language Based Dementias

Start date: March 2010
Phase: Phase 1
Study type: Interventional

The study is designed to determine whether there are clinical features that can be used as biomarkers to predict whether underlying Alzheimer's pathology is the cause of a speech and language based dementia. The primary hypothesis is that the proportion of patients who test positive for beta-amyloid deposition will vary across different speech and language based dementias.

NCT ID: NCT01507636 Completed - Multiple Sclerosis Clinical Trials

Occupational Therapy in Patients With Multiple Sclerosis

Start date: January 2012
Phase: N/A
Study type: Interventional

Limb apraxia is defined as the inability to correctly perform skilled and/or learned limb movements, which cannot be explained by elementary motor and sensory deficits or cognitive problems. Multiple Sclerosis (MS) is a chronic inflammatory disease of the central nervous system and the leading cause of disability in young adults. Apraxia and impaired manual dexterity are common problems in patients with MS leading to impaired activities of daily living. However, a specific training program to improve apraxia as well as manual dexterity in MS is lacking. In this study, the investigators want to evaluate the impact of a targeted occupational therapy program on apraxia and manual dexterity in patients with MS that have dexterity problems. Patients routinely seen in the investigators MS consulting hour, fulfilling all inclusion and exclusion criteria and willing to participate in the study will be evaluated for Apraxia and manual dexterity. In case of Apraxia and/or impaired manual dexterity, patients will be randomized 1:1 using sealed envelopes to receive occupational home therapy (experimental group) or general physical exercises (control group) for 4 weeks. At study entry and study end after 4 weeks, apraxia and manual dexterity will be tested in all patients.

NCT ID: NCT01483807 Completed - Stroke Clinical Trials

Treatments of Acquired Apraxia of Speech

Apraxia
Start date: August 1, 2011
Phase: N/A
Study type: Interventional

This study was designed to examine the effects of speech therapy on ability to produce speech sounds in persons with acquired apraxia of speech.

NCT ID: NCT01315717 Completed - Alzheimer Disease Clinical Trials

Gait and Alzheimer Interaction Tracking (GAIT) Study

GAIT
Start date: November 2009
Phase: N/A
Study type: Observational

The purpose of this study is to examine and to compare gait characteristics under single- and dual-task conditions among healthy subjects together with AD patients at different stages of disease (i.e., pre-dementia, mild and moderate dementia stages).